Search clinical trials for: Immunologic rejection

Total 42009 results

AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
Shahid Beheshti University of Medical Sciences

Unknown

Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Neovascular Age-Related Macular Degeneration

Iran, Islamic Republic of
Hordinsky, Maria K., MD

Completed

Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice

Alopecia

United States
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Rajavithi Hospital
Rajavithi Biomolecular Research Center

Completed

Botulism Outbreak in Thailand (Episode II)

Botulism

Thailand
Meiji University of Oriental Medicine
Kyoto Prefectural University of Medicine

Terminated

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Allergic Conjunctivitis

Japan
University of Ottawa
Canadian Institutes of Health Research (CIHR)

Unknown

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Myocardial Infarction

Canada
Samaritan Pharmaceuticals, Inc

Unknown

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

HIV Infections | Human Immunodeficiency Virus

United States
Hospital Universitario Ramon y Cajal
Novartis; Astellas Pharma Inc

Unknown

Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

Kidney Diseases

Spain
Trial Form Support S.L.
Merck KGaA, Darmstadt, Germany

Unknown

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

Oropharyngeal Neoplasms

Spain
Gruppo Italiano Studio Linfomi

Completed

Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

Follicular Lymphoma

Italy
UMC Utrecht
University Medical Center Groningen; Dutch Arthritis Association

Completed

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Lupus Erythematosus, Systemic | Sjogren's Syndrome

Netherlands
Hospital Clinic of Barcelona

Completed

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

HIV Infections | Lipoatrophy
St. Antonius Hospital

Unknown

Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair

Respiratory Insufficiency | Thoracic Aortic Aneurysm

Netherlands
University of Trieste

Unknown

Avastin for CNV Secondary to Pattern Dystrophy

Choroidal Neovascularization Secondary to Pattern Dystrophy

Italy
London School of Hygiene and Tropical Medicine
European Commission; Development Cooperation Ireland (previously known as Ireland...

Completed

MEMA Kwa Vijana Trial: Impact of an Adolescent Sexual and Reproductive Health Intervention in Mwanza, Tanzania

HIV Infections | Sexually Transmitted Diseases | Pregnancy | Sexual Behavior

Tanzania
University of Bern
University of Zurich

Completed

Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

Coronary Heart Disease

Switzerland
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Centre Hospitalier Universitaire de Nice

Terminated

Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream

Oral Erosive Lichen Planus
Shahid Beheshti University of Medical Sciences

Completed

Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy

Proliferative Vitreoretinopathy

Iran, Islamic Republic of
Hospital Clinic of Barcelona

Terminated

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

HIV Infection

Spain
Odense University Hospital

Completed

Rituximab in the Treatment of Graves' Disease

Thyroid Associated Ophthalmopathy | Graves´ Disease

Denmark
University of Magdeburg

Unknown

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Lymphoma, High-Grade

Germany
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
University Hospital Muenster
Hoffmann-La Roche

Unknown

CYA Versus MMF for Treatment of Moderate-Severe Psoriasis.

Psoriasis

Germany
Bayside Health

Unknown

The Role of Naive T-Cells in HIV Pathogenesis

HIV Infections

Australia
Asan Medical Center

Unknown

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Korea, Republic of
AGO Study Group

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Abbott

Completed

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

HIV Infections

United States
Association of Urologic Oncology (AUO)
Eli Lilly and Company

Unknown

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

Carcinoma, Transitional Cell | Bladder Cancer

Germany
The Alvin and Lois Lapidus Cancer Institute
Ortho Biotech Products, L.P.

Unknown

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

United States
La Jolla Pharmaceutical Company

Completed

Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease

Autoimmune Diseases | Systemic Lupus Erythematosus | Lupus Nephritis | Immunologic Diseases | Lupus Glomerulonephritis

United States, Austria, Canada, France, Germany, Italy, Mexico, Spain, Sweden, United Kingdom
The New York Academy of Medicine
Public Health Solutions

Unknown

Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA

HIV Infections

United States
Public Health Service of Amsterdam

Terminated

Effect Study of a Theory-Based Internet Intervention on Safe-Sex Practices

Sexual Risk Behavior for HIV-Infection

Netherlands
Finnish Institute for Health and Welfare
Merck Sharp & Dohme LLC; Wyeth-Lederle Vaccines; Pasteur Merieux Connaught

Completed

Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine Serotypes

Pneumococcal Infections | Otitis Media

Finland
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Astellas Pharma Inc

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Eli Lilly and Company

Terminated

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Ovarian Cancer | Peritoneal Cancer

United States
Instituto Nacional de Ciencias Medicas y Nutricion...
Instituto Mexicano del Seguro Social; National Council of Science and Technology...

Unknown

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Acquired Immunodeficiency Syndrome

Mexico
Biogen

Terminated

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Ain Shams University
National Institute of Allergy and Infectious Diseases (NIAID); Beth Israel... and other collaborators

Completed

Timing and Duration of Acute Hepatitis C Treatment

Hepatitis C

Egypt
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Terminated

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL

Burkitt Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

LMBA02 Protocol for Patients With a Burkitt Lymphoma

Burkitt Lymphoma

France
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Unknown

Bevacizumab in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Germ Cell Tumor

France
Heidelberg University
Merck KGaA, Darmstadt, Germany

Unknown

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Glioblastoma Multiforme

Germany
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Carcinoma

France
Samsung Medical Center

Completed

Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema

Diabetic Macular Edema

Korea, Republic of
French National Agency for Research on AIDS and...
Hoffmann-La Roche

Terminated

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

HIV Infections | Primary Acute Infection

Search clinical trials for: Immunologic rejection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations